The progression of cancer involves a critical step in which malignant cells escape from
control by the immune system. Antineoplastic agents are particularly efficient when they …

Immunogenic cell death (ICD), which results from insufficient cellular adaptation to specific
stressors, occupies a central position in the development of novel anticancer treatments …

The search for immunostimulatory drugs applicable to cancer immunotherapy may profit
from target‐agnostic methods in which agents are screened for their functional impact on …

Over the last decade, the composition of the gut microbiota has been found to correlate with
the outcomes of cancer patients treated with immunotherapy. Accumulating evidence points …

Lifestyle factors exert profound effects on host physiology and immunology. Disparities in
cancer outcomes persist as a complex and multifaceted challenge, necessitating a …

Recent studies have demonstrated that the antitumor immunity of immune cells can be
modulated by gut microbiota and their metabolites. However, the underlying mechanisms …

Compelling evidence supports the hypothesis that stress negatively impacts cancer
development and prognosis. Irrespective of its physical, biological or psychological source …

Recent observations indicate that the pathogenesis and prognosis of hormone-receptor
breast cancer is not only dictated by the properties of the malignant cells but also by immune …

In a recent paper in Science, Chen et al. reported the genetic engineering of S. epidermidis
expressing tumor cross-reactive antigens that trigger T cell responses and exhibit anticancer …

Although multifactorial in origin, one of the most impactful consequences of social isolation
is an increase in breast cancer mortality. How this happens is unknown, but many studies …